Lung cancer drug trial halted early: what we know
Disease control
Terminated
This early-stage trial tested a new drug called MYTX-011 for people with advanced non-small cell lung cancer (NSCLC) that had spread or come back after standard treatments. The drug is an antibody-drug conjugate designed to deliver a potent chemotherapy directly to cancer cells. …
Phase: PHASE1 • Sponsor: Mythic Therapeutics • Aim: Disease control
Last updated May 08, 2026 12:02 UTC